Immunopathophysiology COVID-19 In Kidney Diseases By Dr Davoud Esmaeili Fellowship Laboratory Medical Sciences
Coronaviridae Coronavirinae subgroups Receptors Hcov-NL63 CD13( APN) Hcov-229E ACE2 α PEDV(Porcine epidemic Virus) CD13 CCov ( Canine Coronavirus) CD13 FIPV( Feline Infectious Peritonitis) CD13 SARS-Cov2( COVID-19) ACE2, CD13, NANA SARS ACE2, CD13, NANA MERS DPP4 β OC43 NANA HKU1 Glycans MHV( Mouse Hepatitis Virus) CEA Bcov( Bovine Coronavirus) NANA
Coronavirinae subgroups Receptors T Cov (Turkey Cov) Ɣ AIBV( Avian Bronchitis Virus) D Cov (Guinea Fowl) Beluga Whale Cov Sw1 δ HKU11 HKU17 Torovirinae Torovirus Baffinvirus
Coronaviridae Classifiaction
General characterization RNA Sense positve Enveloped 80-120 nm ORF Diameter 7-14
Structure
Virus replication penetration Release
Replication
Pathogenesis Respiratory Risk Factors: Gastroenteritis Age ≥ 65 Neurotrpic Daibetic Osteotropic Immunocompromised Liver BMI Cardiomyopathy Dysfunction Kidney, Hypoxia Liver, Lung Skin acne Conjunctivitis AKI
COVID-19 and Nephropathy Sepsis Syndrome CYTOKINE STORMY hypercoagulation AKI Hypert ension , hypote nsion Immune COMPLEX Infiltration MQ, Lymphocyte, Renin-Angiotensin, Aldostron
Laboratory Tests Cr Cytokine Cascade CRP IL-6 ESR IL-1 β Lekopenia TNF α Lymphopenia IL-1 β Inflammation IL-8 Ferritin Chemokines D-dimer IP-10 CD4 MCP-1
Recommend
More recommend